MCID: TRT010
MIFTS: 52

Teratoma

Categories: Cancer diseases, Fetal diseases

Aliases & Classifications for Teratoma

MalaCards integrated aliases for Teratoma:

Name: Teratoma 12 75 55 6 44 15 72
Teratomas 15

Classifications:



External Ids:

Disease Ontology 12 DOID:3307
MeSH 44 D013724
NCIt 50 C3403
SNOMED-CT 68 55818009
UMLS 72 C0039538

Summaries for Teratoma

Disease Ontology : 12 A germ cell and embryonal cancer that is an encapsulated tumor with tissue or organ components resembling normal derivatives of all three germ layers.

MalaCards based summary : Teratoma, also known as teratomas, is related to mature teratoma and sacrococcygeal teratoma. An important gene associated with Teratoma is AFP (Alpha Fetoprotein), and among its related pathways/superpathways are Wnt / Hedgehog / Notch and Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors. The drugs Ribavirin and Palivizumab have been mentioned in the context of this disorder. Affiliated tissues include ovary, testis and thyroid, and related phenotypes are cellular and behavior/neurological

Wikipedia : 75 A teratoma is a tumor made up of several different types of tissue, such as hair, muscle, teeth, or... more...

Related Diseases for Teratoma

Diseases in the Teratoma family:

Malignant Teratoma Adult Teratoma
Intermediate Malignant Teratoma

Diseases related to Teratoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1087)
# Related Disease Score Top Affiliating Genes
1 mature teratoma 34.8 TP53 POU5F1 AFP
2 sacrococcygeal teratoma 34.4 MNX1 CGB7 CGA AFP
3 ovarian germ cell teratoma 34.3 NKX2-1 KRT7
4 malignant teratoma 34.0 TP53 SYP POU5F1 ENO2 AFP
5 dermoid cyst 34.0 MNX1 KRT7 KIT
6 testicular germ cell tumor 33.6 TP53 KIT DMRT1 CGB3 AFP
7 polyembryoma 33.3 CGA AFP
8 cystic teratoma 33.1 TP53 SYP NKX2-1 KRT7 GFAP ENO2
9 testicular cancer 33.0 CGB3 CGA AFP
10 ovarian germ cell cancer 32.9 NKX2-1 KRT7 AFP
11 testicular yolk sac tumor 31.8 POU5F1 CDX2 AFP
12 appendix adenocarcinoma 31.7 KRT7 CDX2
13 nonseminomatous germ cell tumor 31.7 CGB7 AFP
14 chromosomal triplication 31.4 CGB3 CGA AFP
15 mixed germ cell tumor 31.4 KIT CGB3 CGA AFP
16 mucinous adenocarcinoma 31.2 NKX2-1 KRT7 CDX2
17 ovarian mixed germ cell neoplasm 31.2 CGA AFP
18 pseudomyxoma peritonei 31.1 TP53 KRT7 CDX2
19 choriocarcinoma 31.1 CGB7 CGB3 CGA
20 dysgerminoma 31.0 KRT7 KIT ENO2 AFP
21 extragonadal germ cell cancer 31.0 POU5F1 AFP
22 testicular seminoma 30.9 CGB3 CGA AFP
23 embryoma 30.9 POU5F1 KIT CDX2 AFP
24 benign ependymoma 30.9 SYP GFAP ENO2
25 hepatoblastoma 30.8 TP53 KRT7 AFP
26 ectopic pregnancy 30.8 CGB7 CGB3 CGA
27 ganglioneuroma 30.7 SYP GFAP ENO2
28 papilloma of choroid plexus 30.7 TP53 SYP GFAP
29 mediastinal cancer 30.6 SYP KIT AFP
30 ovarian mucinous neoplasm 30.6 SYP KRT7 CDX2
31 oligodendroglioma 30.6 TP53 SYP GFAP ENO2
32 brain germinoma 30.6 POU5F1 AFP
33 carcinosarcoma 30.6 TP53 KRT7 KIT ACTC1
34 tubular adenocarcinoma 30.6 SYP CDX2 AFP
35 extraventricular neurocytoma 30.5 SYP GFAP
36 renal cell carcinoma, papillary, 1 30.5 TP53 KRT7 KIT
37 pineal gland cancer 30.4 SYP GFAP ENO2
38 hydrocephalus 30.4 TP53 SYP NES GFAP ENO2
39 pineocytoma 30.4 SYP GFAP ENO2
40 adenosquamous carcinoma 30.4 TP53 NKX2-1 KRT7 KIT
41 meningioma, familial 30.4 TP53 SYP GFAP ENO2
42 pineoblastoma 30.4 SYP POU5F1 GFAP AFP
43 neuroendocrine tumor 30.3 SYP NKX2-1 KRT7 ENO2
44 embryonal testis carcinoma 30.3 POU5F1 AFP
45 hemangioma 30.3 SYP NKX2-1 ENO2 ACTC1
46 leiomyosarcoma 30.3 TP53 KIT ENO2 ACTC1
47 acinar cell carcinoma 30.3 TP53 KRT7 AFP
48 endocervical adenocarcinoma 30.2 TP53 KRT7 CDX2
49 cervical adenocarcinoma 30.2 TP53 KRT7 CDX2
50 appendix cancer 30.2 TP53 KRT7 CDX2

Graphical network of the top 20 diseases related to Teratoma:



Diseases related to Teratoma

Symptoms & Phenotypes for Teratoma

MGI Mouse Phenotypes related to Teratoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.18 ACTC1 CDX2 ENO2 GFAP GRN KIT
2 behavior/neurological MP:0005386 10.17 AFP ENO2 GFAP GRN KIT MNX1
3 homeostasis/metabolism MP:0005376 10.03 ACTC1 AFP CDX2 CGA GFAP GRN
4 endocrine/exocrine gland MP:0005379 10.02 AFP CDX2 CGA DMRT1 KIT MNX1
5 digestive/alimentary MP:0005381 9.97 CDX2 GFAP KIT MNX1 NKX2-1 POU5F1
6 nervous system MP:0003631 9.9 CGA ENO2 GFAP GRN KIT MNX1
7 normal MP:0002873 9.65 ACTC1 CDX2 GFAP KIT MNX1 NKX2-1
8 reproductive system MP:0005389 9.32 AFP CDX2 CGA DMRT1 GRN KIT

Drugs & Therapeutics for Teratoma

Drugs for Teratoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 194)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ribavirin Approved Phase 3 36791-04-5 37542
2
Palivizumab Approved, Investigational Phase 3 188039-54-5
3
Captopril Approved Phase 3 62571-86-2 44093
4
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
5
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
6
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
7
Caspofungin Approved Phase 3 179463-17-3, 162808-62-0 468682 2826718
8
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
9
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
10
Ondansetron Approved Phase 3 99614-02-5 4595
11
Cisplatin Approved Phase 3 15663-27-1 84093 441203 2767
12
Bleomycin Approved, Investigational Phase 3 11056-06-7 5360373
13
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
14
Mesna Approved, Investigational Phase 3 3375-50-6 598
15
Promethazine Approved, Investigational Phase 3 60-87-7 4927
16
Diphenhydramine Approved, Investigational Phase 3 58-73-1, 147-24-0 3100
17
Vinblastine Approved Phase 3 865-21-4 241903 13342
18 Antiparasitic Agents Phase 3
19 Antiprotozoal Agents Phase 3
20 Antihypertensive Agents Phase 3
21 Angiotensin-Converting Enzyme Inhibitors Phase 3
22 14-alpha Demethylase Inhibitors Phase 3
23 Cytochrome P-450 CYP2C9 Inhibitors Phase 3
24 Cytochrome P-450 CYP3A Inhibitors Phase 3
25 Antifungal Agents Phase 3
26 Cytochrome P-450 Enzyme Inhibitors Phase 3
27 Steroid Synthesis Inhibitors Phase 3
28
Hydroxyitraconazole Phase 3
29 Cytochrome P-450 CYP2C19 Inhibitors Phase 3
30 Liposomal amphotericin B Phase 3
31 Emetics Phase 3
32 Tubulin Modulators Phase 3
33 Antimitotic Agents Phase 3
34 Antibiotics, Antitubercular Phase 3
35 Albumin-Bound Paclitaxel Phase 3
36 Histamine H2 Antagonists Phase 3
37
Chlorpheniramine Approved Phase 1, Phase 2 132-22-9, 113-92-8 2725
38
Furosemide Approved, Vet_approved Phase 1, Phase 2 54-31-9 3440
39
Ranitidine Approved Phase 1, Phase 2 66357-35-5, 66357-59-3 3001055
40
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 1, Phase 2 7487-88-9 24083
41
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
42
Oxaliplatin Approved, Investigational Phase 2 61825-94-3 5310940 9887054 43805 6857599
43
Oprelvekin Approved, Investigational Phase 2 145941-26-0
44
Aldesleukin Approved Phase 2 85898-30-2, 110942-02-4
45
Ciprofloxacin Approved, Investigational Phase 2 85721-33-1 2764
46
Povidone Approved Phase 2 9003-39-8
47
Iodine Approved, Investigational Phase 2 7553-56-2 807
48
Povidone-iodine Approved Phase 2 25655-41-8
49
Docetaxel Approved, Investigational Phase 2 114977-28-5 148124
50
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703

Interventional clinical trials:

(show top 50) (show all 109)
# Name Status NCT ID Phase Drugs
1 SIOP CNS GCT II: Prospective Trial for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Intracranial Germ Cell Tumors Unknown status NCT01424839 Phase 4 Carboplatin, Etoposide, Ifosfamide;Cisplatin, etoposide, Ifosfamide (standard);Cisplatin, Etoposide, Ifosfamide (high dose)
2 A Risk-Adapted Strategy of the Use of Dose-Dense Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors Unknown status NCT00104676 Phase 3 cisplatin;etoposide;ifosfamide;oxaliplatin;paclitaxel
3 Randomized Phase II/III Study of Taxol/Paclitaxel-BEP Versus BEP in Patients With Intermediate Prognosis Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3 cisplatin;etoposide;paclitaxel
4 Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy : A Prospective, Randomized, Controlled Study Unknown status NCT02097446 Phase 3
5 Protocol for the Treatment of Extracranial Germ Cell Tumours in Children and Adolescents (GC III) Unknown status NCT00274950 Phase 3 carboplatin;cisplatin;etoposide;ifosfamide;vinblastine sulfate
6 A Randomized Phase III Study of Sequential High-Dose Cisplatinum/Etoposide/Ifosfamide Plus Stem Cell Support Versus BEP in Patients With Poor Prognosis Germ Cell Cancer Completed NCT00003941 Phase 3 cisplatin;etoposide;ifosfamide
7 A Randomized Double-Blind Placebo-Controlled Phase III Study To Evaluate The Safety And Efficacy Of Palivizumab Combined With Aerosolized Ribavirin Compared To Ribavirin Alone To Treat RSV Pneumonia In Patients With Bone Marrow Transplants (BMT) Completed NCT00014391 Phase 3 ribavirin
8 Phase III Study of Captopril in Patients Undergoing Autologous Bone Marrow/Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
9 A Randomized, Comparative Study of Itraconazole Versus Fluconazole for Prevention of Aspergillus Infections in Peripheral Blood Stem Cell and Marrow Transplant Recipients Completed NCT00003883 Phase 3 fluconazole;itraconazole
10 RANDOMIZED MULTIINSTITUTIONAL PHASE III TRIAL OF BEP AND HIGH DOSE CHEMOTHERAPY VERSUS BEP ALONE IN PREVIOUSLY UNTREATED PATIENTS WITH POOR RISK GERM CELL TUMORS Completed NCT00002596 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide
11 A Multicenter, Double-Blind, Randomized, Comparative Study To Evaluate The Safety, Tolerability, And Efficacy Of MK-0991 Versus (Amphotericin B) Liposome For Injection As Empirical Therapy In Patients With Persistent Fever And Neutropenia Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
12 A Strategic Study to Determine the Optimal Moment to Initiate Systemic Antifungal Therapy With Ambisome in Granulocytopenic Cancer Patients With Unexplained Fever Refractory to Empirical Antibacterials Completed NCT00003938 Phase 3 liposomal amphotericin B
13 A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children Completed NCT00716976 Phase 3 sodium thiosulfate
14 A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors Completed NCT00053352 Phase 3 cisplatin;etoposide
15 Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
16 A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3 Bleomycin;Carboplatin;Cisplatin;Etoposide;Etoposide Phosphate
17 A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors Recruiting NCT02375204 Phase 3 paclitaxel;ifosfamide;cisplatin;pegylated G-CSF;G-CSF;carboplatin;etoposide phosphate
18 A Randomized Phase III Study of Paclitaxel, Ifosfamide and Cisplatin Versus Vinblastine, Ifosfamide and Cisplatin as Second-Line Therapy for Patients With Relapsed/Resistant Germ Cell Tumors Terminated NCT00072215 Phase 3 cisplatin;ifosfamide;paclitaxel;vinblastine
19 Tandem High-Dose Chemotherapy (HDCT) With Peripheral-Blood Stem-Cell Rescue for Patients With Metastatic Germ-Cell Tumors Failing First-Line Treatment Unknown status NCT01172912 Phase 2 carboplatin;cisplatin;dexamethasone;etoposide;ifosfamide
20 Phase I/II Multicentre Trial of Salvage Chemotherapy With Gem-TIP for Relapsed Germ Cell Cancer Unknown status NCT00551122 Phase 1, Phase 2 cisplatin;gemcitabine hydrochloride;ifosfamide;paclitaxel
21 A Multicenter, Randomized, Controlled Study of the Efficacy and Safety of the Combination of Adipose Tissue-derived Hematopoietic Stem Cells (AD-HSCs) and ATG in the Treatment of Severe Aplastic Anemia Unknown status NCT02407470 Phase 1, Phase 2 Rabbit antithymoglobulin (ATG)
22 Adnexectomy for Benign Gynaecological Pathology by Natural Orifice Transluminal Endoscopy or Laparoscopy Unknown status NCT02630329 Phase 2
23 A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression Completed NCT02300987 Phase 2 LEE011;LEE011 Placebo
24 A Phase II Study of Sunitinib in Patients With Refractory or Relapsed Germ Cell Tumors Completed NCT00453310 Phase 2 sunitinib malate
25 A Phase II Study of BMS-247550 In Advanced Germ Cell Tumor Patients - THERAPEUTIC/DIAGNOSTIC PROTOCOL Completed NCT00070096 Phase 2 ixabepilone
26 Accelerated BEP Chemotherapy for Intermediate and High Risk Metastatic Germ Cell Tumor Completed NCT00453232 Phase 2 cisplatin;etoposide
27 Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Previously Untreated Intermediate and Poor Risk Germ Cell Tumor Patients Completed NCT00470366 Phase 2 cisplatin;ifosfamide;paclitaxel
28 Tandem High-Dose Chemotherapy With Autologous Stem Cell Rescue for Poor-Prognosis Germ Cell Cancer Completed NCT00002931 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel
29 A Study of Paclitaxel, Cisplatin and Ifosfamide as Induction Therapy in the Treatment of Patients Relapsing After BEP Chemotherapy for Metastatic Germ Cell Tumors Completed NCT00004077 Phase 2 cisplatin;ifosfamide;paclitaxel
30 Randomized Phase II Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP Chemotherapy in Poor Prognosis Male Germ Cell Tumors Completed NCT00301782 Phase 2 carboplatin;cisplatin;etoposide phosphate;vincristine sulfate
31 A PHASE II STUDY OF CELLULAR ADOPTIVE IMMUNOTHERAPY AS PROPHYLAXIS FOR CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION Completed NCT00002673 Phase 2
32 Oral Beclomethasone Dipropionate Capsules for Treatment of Intestinal Graft-Versus-Host Disease: Compassionate Use in Patients With Contraindictions to High-Dose Immunosuppressive Therapy Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
33 Combination of Interleukin 11 (Neumega) With G-CSF to Mobilize Autologous Peripheral Blood Stem Cells (PBSC) Completed NCT00004157 Phase 2
34 Donor Lymphocyte Infusion (DLI) as Adoptive Immunotherapy for Relapse Malignancies After Allogeneic Hematopoietic Transplantation Completed NCT00003887 Phase 2
35 Cytokine-Based Immunotherapy Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation Completed NCT00003408 Phase 2
36 Phase I/II Trial of Sequential Paclitaxel/Ifosfamide Followed by Dose-Escalated, Dose-Intensive Carboplatin, Paclitaxel and Ifosfamide With Stem Cell Support in Cisplatin-Resistant Germ Cell Tumor Patients Completed NCT00423852 Phase 1, Phase 2 carboplatin;ifosfamide;paclitaxel
37 Phase 2 Study Of Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa Completed NCT01560715 Phase 2
38 Phase II Pre-Irradiation Chemotherapy for Central Nervous System Germ Cell Malignancies Completed NCT00002472 Phase 2 cisplatin;etoposide
39 A Phase II Study of Oxaliplatin in Children With Recurrent Solid Tumors Completed NCT00091182 Phase 2 oxaliplatin
40 PHASE II TRIAL WITH DOCETAXEL IN PATIENTS WITH RELAPSING GERM CELL CANCER Completed NCT00002903 Phase 2 docetaxel
41 Phase II Treatment of Children With Newly Diagnosed Malignant Central Nervous System Tumors With Temozolomide Prior to Radiation Therapy Completed NCT00005955 Phase 2 temozolomide
42 High-Dose Cisplatin, Etoposide and Bleomycin (HD-PEB) Combined With Amifostine in Children With High-Risk Malignant Germ Cell Tumors - A POG Pilot Study Completed NCT00003811 Phase 2 amifostine trihydrate;cisplatin;etoposide
43 High-Dose Thiotepa With Autologous Stem Cell Rescue in Patients With Malignancies Refractory to Conventional Chemotherapy Completed NCT00003173 Phase 2 thiotepa
44 A Phase II Study To Assess The Ability Of Neoadjuvant Chemotherapy Plus/Minus Second Look Surgery To Eliminate All Measurable Disease Prior To Radiotherapy For NGGCT Completed NCT00047320 Phase 2 carboplatin;etoposide;ifosfamide;thiotepa
45 PROTOCOL FOR THE TREATMENT OF MALIGNANT NON-TESTICULAR GERM CELL TUMORS Completed NCT00002489 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;leucovorin calcium;methotrexate;vincristine sulfate
46 Phase II Study of Avelumab in Multiple Relapsed/Refractory Testicular Germ Cell Cancer. Completed NCT03403777 Phase 2 Avelumab
47 Sequential High-Dose Chemotherapy Combining Two Mobilization and Cyto-Reductive Treatments Followed by Three High-Dose Chemotherapy Regimens Supported by Autologous Stem Cell Transplantation Completed NCT00231582 Phase 2 epirubicin;paclitaxel;etoposide;ifosfamide;carboplatin
48 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Recruiting NCT00432094 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel;thiotepa;Mesna
49 Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic Acid (Axumin) Positron Emission Tomography/Computed Tomography Prior to Retroperitoneal Lymph Node Dissection for Testicular Cancer Recruiting NCT03426865 Phase 2 Axumin PET scan
50 Phase II Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer Recruiting NCT02860819 Phase 2 Veliparib;Gemcitabine;Carboplatin

Search NIH Clinical Center for Teratoma

Cochrane evidence based reviews: teratoma

Genetic Tests for Teratoma

Anatomical Context for Teratoma

MalaCards organs/tissues related to Teratoma:

41
Ovary, Testis, Thyroid, Pineal, Brain, Lymph Node, Bone

Publications for Teratoma

Articles related to Teratoma:

(show top 50) (show all 14138)
# Title Authors PMID Year
1
Generation of induced pluripotent stem cells from newborn marmoset skin fibroblasts. 9 38
20363201 2010
2
Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells. 9 38
19785009 2010
3
Tumour microvessel endothelial cell KIT and stem cell factor expression in human solid tumours. 9 38
19912360 2009
4
Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. 9 38
19826408 2009
5
Basic FGF and Activin/Nodal but not LIF signaling sustain undifferentiated status of rabbit embryonic stem cells. 9 38
19331817 2009
6
Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein. 9 38
19493258 2009
7
Alpha-fetoprotein levels correlate with the pathologic grade and surgical outcomes of pediatric retroperitoneal teratomas. 9 38
19198853 2009
8
Yolk sac tumor but not seminoma or teratoma is associated with abnormal epigenetic reprogramming pathway and shows frequent hypermethylation of various tumor suppressor genes. 9 38
19245437 2009
9
Progression from an immature teratoma with miliary gliomatosis peritonei to growing teratoma syndrome with nodular gliomatosis peritonei. 9 38
19453084 2009
10
Isolation of three stem cell lines from human sacrococcygeal teratomas. 9 38
19142973 2009
11
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection. 9 38
19156903 2009
12
Pineal region tumors--neurosurgical review. 9 38
20088167 2009
13
Mixed ovarian large cell neuroendocrine carcinoma, mucinous adenocarcinoma, and teratoma: a report of two cases and review of the literature. 9 38
19577382 2009
14
Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiation. 9 38
18611917 2008
15
Neuron-like differentiation and selective ablation of undifferentiated embryonic stem cells containing suicide gene with Oct-4 promoter. 9 38
18393636 2008
16
The distinction of bronchogenic cyst from metastatic testicular teratoma: a light microscopic and immunohistochemical study. 9 38
18628097 2008
17
Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study. 9 38
18525461 2008
18
Immunohistochemical localization of nanog and Oct4 in stem cell compartments of human sacrococcygeal teratomas. 9 38
18439155 2008
19
Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. 9 38
18277882 2008
20
Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. 9 38
18062871 2007
21
Analyses of novel prognostic factors in neuroblastoma patients. 9 38
18057715 2007
22
FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin. 9 38
17875810 2007
23
Expression of Sox2 in mature and immature teratomas of central nervous system. 9 38
17464316 2007
24
Regulated Nodal signaling promotes differentiation of the definitive endoderm and mesoderm from ES cells. 9 38
17535850 2007
25
[Malignant ovarian germ cell tumours: a trial of 36 cases]. 9 38
17350873 2007
26
Glypican 3: a novel marker in testicular germ cell tumors. 9 38
17122513 2006
27
Oncofetal protein glypican-3 in testicular germ-cell tumor. 9 38
16896894 2006
28
Characterization and gene expression profiling of five new human embryonic stem cell lines derived in Taiwan. 9 38
16978057 2006
29
Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma. 9 38
16718353 2006
30
Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. 9 38
16596424 2006
31
TGF-beta2 allows pluripotent human embryonic stem cell proliferation on E6/E7 immortalized mouse embryonic fibroblasts. 9 38
16494961 2006
32
Pineal region teratoma with high serum and CSF alpha-fetoprotein levels. 9 38
16503489 2006
33
Malignant cervical teratoma: report of a case in a newborn. 9 38
15895292 2005
34
Transcription factor GATA-6 is expressed in malignant endoderm of pediatric yolk sac tumors and in teratomas. 9 38
16006960 2005
35
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 9 38
15774903 2005
36
Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. 9 38
16512597 2005
37
Interpretation of alpha-fetoprotein concentrations in cerebrospinal fluid of infants. 9 38
15802029 2005
38
Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors. 9 38
15613854 2005
39
[The value of cytology in the diagnosis of extragonadal germ cell tumors]. 9 38
15567952 2004
40
Epidemiological and clinical behavior of prepubertal testicular tumors in Korea. 9 38
15247758 2004
41
[Clinical usefulness of circulating tumor markers]. 9 38
15272600 2004
42
Nestin, a neuroectodermal stem cell marker molecule, is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours. 9 38
15127288 2004
43
Intracranial germ cell tumors: a single institution experience and review of the literature. 9 38
15218952 2004
44
Prenatal diagnosis of sacrococcygeal teratoma with constitutional partial monosomy 7q/trisomy 2p. 9 38
14663834 2003
45
Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. 9 38
12161760 2002
46
Apoptosis and proliferative activity in mature and immature teratomas of the mediastinum. 9 38
11745252 2001
47
Malignant teratoma of the thyroid with primitive neuroepithelial and mesenchymal sarcomatous components. 9 38
11598856 2001
48
Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. 9 38
10760271 2000
49
Transcription factor GATA-4 is expressed in pediatric yolk sac tumors. 9 38
10595911 1999
50
Methylation imprinting of H19 and SNRPN genes in human benign ovarian teratomas. 9 38
10521301 1999

Variations for Teratoma

ClinVar genetic disease variations for Teratoma:

6
# Gene Variation Type Significance SNP ID GRCh37 Pos GRCh38 Pos
1 CTNNB1 NM_001904.4(CTNNB1): c.1876G> T (p.Glu626Ter) single nucleotide variant Likely pathogenic rs1553632357 3:41277912-41277912 3:41236421-41236421
2 SETBP1 NM_015559.3(SETBP1): c.2614G> A (p.Gly872Arg) single nucleotide variant Likely pathogenic rs1555706928 18:42531919-42531919 18:44951954-44951954

Expression for Teratoma

Search GEO for disease gene expression data for Teratoma.

Pathways for Teratoma

GO Terms for Teratoma

Cellular components related to Teratoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.56 KIT GRN ENO2 CGB7 CGB3 CGA
2 cytoplasm GO:0005737 9.47 TP53 SOX2 POU5F1 NES KRT7 KIT

Biological processes related to Teratoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of transcription by RNA polymerase II GO:0000122 9.8 TP53 SOX2 POU5F1 NKX2-1 DMRT1 CDX2
2 positive regulation of gene expression GO:0010628 9.55 TP53 POU5F1 NKX2-1 KIT ACTC1
3 response to wounding GO:0009611 9.54 SOX2 POU5F1 GFAP
4 germ cell migration GO:0008354 9.26 KIT DMRT1
5 endodermal cell fate specification GO:0001714 8.96 SOX2 POU5F1
6 somatic stem cell population maintenance GO:0035019 8.92 SOX2 POU5F1 KIT CDX2

Molecular functions related to Teratoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sequence-specific DNA binding GO:0043565 9.43 SOX2 POU5F1 NKX2-1 MNX1 DMRT1 CDX2
2 RNA polymerase II distal enhancer sequence-specific DNA binding GO:0000980 9.33 TP53 NKX2-1 CDX2
3 DNA-binding transcription factor activity GO:0003700 9.17 TP53 SOX2 POU5F1 NKX2-1 MNX1 DMRT1

Sources for Teratoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....